Cytosorbents (CTSO)
(Delayed Data from NSDQ)
$1.13 USD
+0.01 (0.89%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $1.13 0.00 (0.00%) 6:22 PM ET
NA Value
NA Growth NA Momentum NA VGMCytoSorbents (CTSO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$5.00 | $10.00 | $1.00 | 346.43% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for CytoSorbents comes to $5.00. The forecasts range from a low of $1.00 to a high of $10.00. The average price target represents an increase of 346.43% from the last closing price of $1.12.
Analyst Price Targets (3 )
Broker Rating
CytoSorbents currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 1.50 a month ago based on four recommendations.
Of the three recommendations deriving the current ABR, two are Strong Buy, representing 66.67% of all recommendations. A month ago, Strong Buy represented 75%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 3 | 3 | 3 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.67 | 1.50 | 1.50 | 1.50 | 1.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/14/2024 | H.C. Wainwright & Co. | Sean Lee | Hold | Hold |
7/29/2024 | EF Hutton Financial | Jason Kolbert | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.67 |
ABR (Last week) | 1.50 |
# of Recs in ABR | 3 |
Average Target Price | $5.00 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 72 of 252 |
Current Quarter EPS Est: | -0.07 |
CTSO FAQs
Cytosorbents Corporation (CTSO) currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 3 brokerage firms.
The average price target for Cytosorbents Corporation (CTSO) is $5.00. The current on short-term price targets is based on 2 reports.
The forecasts for Cytosorbents Corporation (CTSO) range from a low of $1 to a high of $10. The average price target represents a increase of $346.43 from the last closing price of $1.12.
The current UPSIDE for Cytosorbents Corporation (CTSO) is 346.43%
Based on short-term price targets offered by three analysts, the average price target for CytoSorbents comes to $5.00. The forecasts range from a low of $1.00 to a high of $10.00. The average price target represents an increase of 346.43% from the last closing price of $1.12.